79
Views
11
CrossRef citations to date
0
Altmetric
Review

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors

&
Pages 337-345 | Published online: 25 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rui Wang, Zhilin Luo, Hong Zhang & Tianhu Wang. (2019) Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway. OncoTargets and Therapy 12, pages 9355-9365.
Read now
Robert G. Mennel. (2015) Precision Medicine: Hype or Hope?. Baylor University Medical Center Proceedings 28:3, pages 397-400.
Read now
Robert G. Mennel. (2015) Precision Medicine: Hype or Hoax?. Baylor University Medical Center Proceedings 28:3, pages 397-400.
Read now

Articles from other publishers (8)

Yu-Jin Wang, Qing-Wen Wang, Dong-Hu Yu, Cong-Kuan Song, Zi-Xin Guo, Xiao-Ping Liu, Chen Chen, Jie Yao, Ai-Fen Wang & Wei-Dong Hu. (2021) Osteopontin improves sensitivity to tyrosine kinase inhibitor in lung adenocarcinoma in vitro by promoting epidermal growth factor receptor phosphorylation. Journal of Cancer Research and Clinical Oncology 147:11, pages 3245-3254.
Crossref
Jen-Chung Ko, Jyh-Cheng Chen, Chia-Li Wei, Li-Ling Liu, Chin-Cheng Chien, I-Hsiang Huang, Jou-Min Hsieh, Chen-Shan Chiang, Pei-Yu Tseng, Hsiang-Hung Cheng, Yong-Cing Tsao & Yun-Wei Lin. (2021) Downregulation of p38 MAPK Activation and Radiation-Sensitive 52 Expression Enhances 5-Fluorouracil and Erlotinib-Induced Cytotoxicity in Human Lung Squamous Cells. Pharmacology 106:11-12, pages 623-636.
Crossref
Chia-Yi Lin, Hsin-Yi Wu, Yuan-Ling Hsu, Ting-Jen Rachel Cheng, Jyung-Hurng Liu, Rou-Jie Huang, Tzu-Hung Hsiao, Chia-Jen Wang, Pei-Fang Hung, Albert Lan, Szu-Hua Pan, Rong-Jie Chein, Chi-Huey Wong & Pan-Chyr Yang. (2020) Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance Protein. Journal of Medicinal Chemistry 63:6, pages 3172-3187.
Crossref
Linfan Zhang, Nikta Feizi, Chen Chi & Pingzhao Hu. (2018) Association Analysis of Somatic Copy Number Alteration Burden With Breast Cancer Survival. Frontiers in Genetics 9.
Crossref
Yi-Ting Wang, Szu-Hua Pan, Chia-Feng Tsai, Ting-Chun Kuo, Yuan-Ling Hsu, Hsin-Yung Yen, Wai-Kok Choong, Hsin-Yi Wu, Yen-Chen Liao, Tse-Ming Hong, Ting-Yi Sung, Pan-Chyr Yang & Yu-Ju Chen. (2017) Phosphoproteomics Reveals HMGA1, a CK2 Substrate, as a Drug-Resistant Target in Non-Small Cell Lung Cancer. Scientific Reports 7:1.
Crossref
Ting-Chun Kuo, Ling-Wei Li, Szu-Hua Pan, Jim-Min Fang, Jyung-Hurng Liu, Ting-Jen Cheng, Chia-Jen Wang, Pei-Fang Hung, Hsuan-Yu Chen, Tse-Ming Hong, Yuan-Ling Hsu, Chi-Huey Wong & Pan-Chyr Yang. (2016) Purine-Type Compounds Induce Microtubule Fragmentation and Lung Cancer Cell Death through Interaction with Katanin. Journal of Medicinal Chemistry 59:18, pages 8521-8534.
Crossref
Corey A. Carter, Bryan T. Oronsky, Scott Z. Caroen, Jan J. Scicinski, Pedro Cabrales, Tony Reid, Aiste Degesys, John Jenkins & Christina Brzezniak. (2016) Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization. Case Reports in Oncology 9:1, pages 62-67.
Crossref
Barbara Grumbt, Sebastian H. Eck, Tanja Hinrichsen & Kaimo Hirv. (2013) Diagnostic Applications of Next Generation Sequencing in Immunogenetics and Molecular Oncology. Transfusion Medicine and Hemotherapy 40:3, pages 196-206.
Crossref